ISIN | LU2207278073 |
---|---|
Valorennummer | 57670939 |
Bloomberg Global ID | |
Fondsname | Kieger Impact Healthcare Fund Class A USD Accumulating |
Fondsanbieter |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Telefon: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
Fondsanbieter | Kieger AG |
Vertreter in der Schweiz |
ACOLIN Fund Services AG Zürich Telefon: +41 44 396 96 96 |
Distributor(en) | |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
Investment-Strategie *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related companies or issuers worldwide (including Emerging Markets) with a focus on issuers that contribute to the realisation of the healthcare related United Nations Sustainable Development Goals ("SDGs"). No guarantee can be given that the investment objective will be achieved. |
Besonderheiten |
Aktueller Preis * | 86.16 USD | 04.02.2025 |
---|---|---|
Vorheriger Preis * | 86.08 USD | 03.02.2025 |
52 Wochen Hoch * | 88.10 USD | 16.07.2024 |
52 Wochen Tief * | 78.16 USD | 19.12.2024 |
NAV * | 86.16 USD | 04.02.2025 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 86'495'950 | |
Anteilsklassevermögen *** | 82'986'222 | |
Trading Information SIX |
YTD-Performance | +9.88% |
31.12.2024 - 04.02.2025
31.12.2024 04.02.2025 |
---|---|---|
YTD-Performance (in CHF) | +9.57% |
31.12.2024 - 04.02.2025
31.12.2024 04.02.2025 |
1 Monat | +6.65% |
06.01.2025 - 04.02.2025
06.01.2025 04.02.2025 |
3 Monate | +6.19% |
04.11.2024 - 04.02.2025
04.11.2024 04.02.2025 |
6 Monate | +6.23% |
05.08.2024 - 04.02.2025
05.08.2024 04.02.2025 |
1 Jahr | +3.38% |
05.02.2024 - 04.02.2025
05.02.2024 04.02.2025 |
2 Jahre | -5.61% |
06.02.2023 - 04.02.2025
06.02.2023 04.02.2025 |
3 Jahre | -10.96% |
04.02.2022 - 04.02.2025
04.02.2022 04.02.2025 |
5 Jahre | -13.84% |
30.09.2020 - 04.02.2025
30.09.2020 04.02.2025 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Exact Sciences Corp | 3.90% | |
---|---|---|
Abbott Laboratories | 3.60% | |
Sandoz Group AG Registered Shares | 3.58% | |
BioNTech SE ADR | 3.51% | |
Amplifon SpA Az nom Post Frazionamento | 3.49% | |
DexCom Inc | 3.49% | |
Demant AS | 3.47% | |
Hikma Pharmaceuticals PLC | 3.46% | |
Novo Nordisk AS Class B | 3.45% | |
Gilead Sciences Inc | 3.45% | |
Letzte Daten-Aktualisierung | 30.11.2024 |
TER *** | 1.21% |
---|---|
Datum TER *** | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | 1.17% |
SRRI ***
|
|
Datum SRRI *** | 31.01.2025 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** |
Sustainable Investment |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |